Le Lézard
Classified in: Health, Business
Subject: TNM

Pharos Capital's Family Treatment Network Acquires ABA of North Texas


DALLAS and NASHVILLE, Tenn., Nov. 28, 2018 /PRNewswire/ -- Pharos Capital Group, LLC ("Pharos"), through its Family Treatment Network platform ("FTN"), has acquired ABA of North Texas ("ABANT"), an outpatient autism services provider based in Plano, TX, the firm announced today. Terms of the transaction were not disclosed. 

"Pharos is committed to expanding our portfolio of behavioral health companies, and we are delighted when we find a fit as harmonious as this one," said Bob Crants, Partner at Pharos. "With its early childhood focus, ABA of North Texas will build on the services offered by sister FTN company Behavior Care Specialists and will further strengthen our ability to offer the applied behavior analysis model of autism treatment." ABANT and Behavior Care Specialists ("BCS") together offer autism services across seven states: Colorado, Connecticut, Iowa, Minnesota, South Dakota, Texas, and Wyoming.

ABA of North Texas provides high quality behavioral services for children and adolescents with autism and other developmental disabilities. Founded in 2012, the company has 33 employees and serves over 70 children across two offices in Plano and McKinney. Founder and CEO Susan Krejci, a Board-Certified Behavior Analyst and certified special education teacher, and her team will continue to provide services under the ABANT name.

Ed Irby, a longtime behavioral health and special education executive who serves as CEO and Chairman of the FTN platform, said, "ABA of North Texas is an important addition to the FTN network. The need for specialized autism services is enormous and growing, and we believe near-term expansion opportunities exist both in their home market of north Texas and into neighboring Oklahoma." 

Alison Hulshof, Chief Executive Officer of Development & Operations of BCS, added, "Children and adolescents are receiving proven benefits from ABANT's therapy, and we are proud to join up with Susan and her team who have a strong reputation for quality and caring treatment."

Ms. Krejci commented, "We are thrilled to be working with FTN and Pharos. They clearly share our vision of providing caring, high quality treatment services to children and their families, and their resources will be invaluable in ensuring greater access for those who need services like ours."

Pharos established its Family Treatment Network platform in 2015 to manage its investments in special schools, psychiatric residential treatment centers and community-based programs for children, adolescents and their families. In addition to ABANT, Family Treatment Network now includes Logan River Academy, a Logan, Utah-based adolescent treatment center; BCS, a South Dakota-based outpatient treatment provider of autism spectrum disorder (ASD) services; and Solterra Academy, a special education day school in Connecticut.  

To learn more about a partnership with The Family Treatment Network and Pharos Capital Group please visit www.pharosfunds.com or contact Adam Persiani at 214-740-7003 or [email protected].

About Family Treatment Network
The Family Treatment Network (FTN) is a complementary platform of child and adolescent behavioral health services businesses, including residential therapy centers, therapeutic day schools, home & community-based outpatient programs, and other child and adolescent psychiatric treatment services. With a strong emphasis on both education and therapy, FTN offers a broad mix of high quality programs and services with an emphasis on autism and ABA Therapy. FTN's goal is to provide best-in-class care across the full continuum of behavioral health services to children, adolescents and families from coast to coast.

About ABA of North Texas
ABA of North Texas provides high quality behavioral services for children and adolescents with autism and other developmental disabilities. Founded in 2012, the company has 33 employees and serves over 70 children across two offices in Plano and McKinney. The company uses the principles of Applied Behavior Analysis, which is generally recognized as the scientific standard for autism treatment.

About Pharos Capital Group 
Based in Dallas and Nashville, Pharos Capital Group (www.pharosfunds.com) is an SEC Registered Investment Advisor. Since inception, Pharos has invested in 53 companies and currently has over $780 million of private equity assets under management. Pharos typically invests $25-$50 million in rapidly growing middle market companies seeking later stage funding for internal growth, acquisitions, leveraged buyouts, management buyouts, or recapitalizations predominantly across healthcare sectors.

Contact
Caroline Luz
Owen Blicksilver Public Relations, Inc.
203-656-2829
[email protected]

SOURCE Pharos Capital Group


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: